약학회지 (YAKHAK HOEJI)

  • 제53권3호
  • /
  • Pages.101-106
  • /
  • 2009
  • /
  • 0377-9556(pISSN)
  • /
  • 2383-9457(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

유전자재조합 인터페론 알파의 HPLC-PDA에 의한 함량분석

The Quantitative HPLC-PDA Method for Recombinant Interferon Alpha Analysis

  • 발행 : 2009.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Recombinant interferon alpha-2a is an active formula for the treatment of various cancer cells like malignant melanoma and a variety of virus infection diseases like acute or chronic hepatitis. The bioassay system based on the measurement of virus inhibitory activity by interferon has been used for interferon analysis with low repeatability. Here, we developed the HPLC assay to measure reproducibly interferon alpha-2a protein content which is replaceable to the reported bioassay. This method separated interferon alpha-2a from its oxidized forms and human serum albumin used as excipients. The regression coefficient using interferon alpha-2a EP CRS is more than 0.9 in the range from 5 ${\mu}g/ml$ to 200 ${\mu}g/ml$. The recovery result in the range from 15 ${\mu}g/ml$ to 60 ${\mu}g/ml$ is $97{\sim}104%$ and the precision is $0.2{\sim}1.7%$. The interferon alpha contents of 5 products are about 30 ${\mu}g/ml$.

키워드

참고문헌

  1. Issac, A. and Lindenmann, J. : Virus interfernce I. The interferon: Proc. R. Soc. Lond. B. Biol. Sci. 147, 258 (1957) https://doi.org/10.1098/rspb.1957.0048
  2. Meager, A., Interferon Alpha, Beta and Omega : Cytokines, Academic Press. UK pp361-380 (1998)
  3. Edward, De M. and Jaqueline, De M. : The Cytokine Handbook, 3rd Edition, Academic Press, UK, pp491-516 (1998)
  4. Mahon, F. X., Fabères, C., Pueyo, S., Cony-Makhoul, P., Salmi, R., Boiron, J. M., Marit, G., Bilhou-Nabera, C., Carrere, A., Montastruc, M., Pigneux, A., Bernard, Ph. and Reiffers, J., Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha. Blood 92, 4059 (1998)
  5. Kirkwood, J. : Cancer immunotherapy: the interferon-alpha experience. Semin. Oncol. 29, 18 (2002) https://doi.org/10.1053/sonc.2002.37464
  6. Bayraktar, Y., Koseoglu, T., Somner, C., Kayhan, B., Temizer, A., Uzunalimoglu, B., De Maria, N. and Van Thiel, D. H. : The use of deferoxamine infusions to enhance the response to interferon-α treatment of chronic viral hepatitis B. J. Viral Hepat. 3, 129 (1996) https://doi.org/10.1111/j.1365-2893.1996.tb00003.x
  7. Federici, M. Marcia : The Quality control of biotechnology products. Biologicals 22, 151 (1994) https://doi.org/10.1006/biol.1994.1021
  8. Yuan-yuan H. Chui, John L. Gueriguian : Drug Biotechnology Regulation-Scientific Basis and Practices, Marcel Dekker Inc. pp341-354 (1991)
  9. Mire-Sluis, A. R., Page, L. and Thorpe R. : Quantitative cell line based bioassays for human cytokines. J. Immunol. Methods 187, 191 (1995)
  10. European Pharmacopoeia 2007 Somatropin concentrated solution, 1110 (2007)
  11. Meager, A. : Biological assays for interferons. Journal of Immunological Methods 261, 21 (2002) https://doi.org/10.1016/S0022-1759(01)00570-1
  12. 식품의약품안전청 고시, 제2005-70호, 생물학적제제기준및시험방법, 주사용 건조 인터페론 2알파-2a
  13. Geigert, J., Ziegler, D. L., Panschar, B. M., Creasey, A. A. and Vitt, C. R. : Potency stability of recombinant (Ser-17) human inteferon-beta. J. Interferon Research 7(2), 203 (1987) https://doi.org/10.1089/jir.1987.7.203
  14. European Pharmacopoeia 2007 Interferon alfa-2a concentrated solution, 1110
  15. Itoh, H., Nimura, N., Kinoshita, T., Nagae, N. and Nomura, M. : Fast protein separation by reversed-phase high-performance liquid chromatography on octadecylsilyl-bonded nonporous silica gel. Analytical Biochemistry 199, 7 (1991) https://doi.org/10.1016/0003-2697(91)90261-Q
  16. EDQM, Collaborative study for establishment of an HPLC potency assay for batch consistency control of recombinant interferon alfa-2, Pharmeuropa Bio 2002.1-June (2002)
  17. Qian, J., Tang, Q., Cronin, B., Markovich, R. and Rustum, A. : Development of a high performance size exclusion chromatography method to determine the stability of human serum albumin in a lyophilized formulation of interferon alfa-2b. J. Chromatography A 1194, 48 (2008) https://doi.org/10.1016/j.chroma.2008.01.040
  18. Elton, T. S. and Reeves, R. : Microheterogeneity of the mammalian high mobility group (HMG) protein and 2 investigated by reverse-phase high performance liquid chromatography. Analytical Biochemistry 144, 403 (1985) https://doi.org/10.1016/0003-2697(85)90133-2
  19. ICH Guideline. Q2(R) : Validation of Analytical Procedures : Test and Methodology
  20. Hochuli, E. : Interferon immunogenicity: technical evaluation of interferon-alpha 2a. J. Interferon Cytokine Res. 17(l), S15 (1997)
  21. Ryff, J. C. : Clinical Investigation of the immunogenicity of interferon alpha 2a. J. Interferon Cytokine Res. 17(1), S29 (1997)
  22. 대한약전 9개정, 일반시험법, 액체크로마토그래프법
  23. FDA Guideline, Interferon test procedures : Point to consider in the production and testing of interferon intended for investigational use in humans
  24. ICH Guideline. Q6B : Specifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products